Microbiology
-
Coronavirus activates a stem cell-mediated defense mechanism that reactivates dormant tuberculosis: implications in COVID-19 pandemic
This article has 9 authors:Reviewed by ScreenIT
-
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
This article has 13 authors:Reviewed by ScreenIT
-
Neutralization of SARS-CoV-2 by destruction of the prefusion Spike
This article has 24 authors:Reviewed by ScreenIT
-
Multiple SARS-CoV-2 introductions shaped the early outbreak in Central Eastern Europe: comparing Hungarian data to a worldwide sequence data-matrix
This article has 22 authors:Reviewed by ScreenIT
-
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2
This article has 12 authors:Reviewed by ScreenIT
-
Selectomic and Evolvability Analyses of the Highly Pathogenic Betacoronaviruses SARS-CoV-2, SARS-CoV, and MERS-CoV
This article has 3 authors:Reviewed by ScreenIT
-
Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids
This article has 29 authors:Reviewed by ScreenIT
-
Pathogen Reduction of SARS-CoV-2 Virus in Plasma and Whole Blood using Riboflavin and UV Light
This article has 5 authors:Reviewed by ScreenIT
-
PSGL-1 inhibits the virion incorporation of SARS-CoV and SARS-CoV-2 spike glycoproteins and impairs virus attachment and infectivity
This article has 8 authors:Reviewed by ScreenIT
-
Release of potential pro-inflammatory peptides from SARS-CoV-2 spike glycoproteins in neutrophil-extracellular traps
This article has 2 authors:Reviewed by ScreenIT